Psychedelics and regulatory advisor, Courtney Barnes, recently appeared on Benzinga's Cannabis Insider show to discuss the evolving landscape of the psychedelics industry. Barnes, who has been in the cannabis and psychedelic space for her entire legal career, shared her insights on various topics related to psychedelics law, including drafting bills, policy reform, and drug development.

Barnes explained that psychedelics, including psilocybin, DMT, LSD, and others, are classified as Schedule I controlled substances at the federal level. However, there has been a recent push for policy reform at the grassroots level, with 19 cities and …

Full story available on Benzinga.com